Rainbow Children's Medicare Ltd Q2 Revenue Rises 23.2% to ₹548 Crore

Rainbow Children's Medicare Ltd reported Q2 FY27 operating revenue of ₹548 crore, up 23.2% year on year, supported by higher patient volumes despite a seasonally soft quarter. EBITDA rose 14.2% to ₹170 crore and the hospital operator recorded a 31% EBITDA margin for the quarter ended September 30, 2026.

What did Rainbow report for Q2 FY27?

Rainbow reported consolidated revenue of ₹548 crore for Q2 FY27, compared with the corresponding quarter a year earlier. The company said operating revenue increased 23.2% year on year, while EBITDA grew 14.2% to ₹170 crore. Net profit was ₹83.9 crore, up 10.9% year on year.

The reported revenue growth exceeded the rise in EBITDA and profit, indicating that profitability increased at a slower pace than the top line during the quarter. EBITDA margin stood at 31%, while the margin for the first half of FY27 was 29.9%. The company described the July-September period as seasonally soft, making the volume growth notable in the context of the quarter.

How did patient volumes and capacity change?

Rainbow recorded growth in inpatient, outpatient and delivery volumes during Q2 FY27. Inpatient discharges rose 15% year on year to 32,706, outpatient consultations increased 19% to 507,114, and deliveries grew 20% to 5,719.

Capacity also expanded during the quarter. Operational beds increased 18% year on year to 1,910, aided by new hospitals in Nellore and Guntur. The company’s expansion added capacity faster than inpatient discharges, which affected the utilisation ratio reported for the period.

Occupancy stood at 49.2%, compared with 52.0% in the year-earlier quarter. A lower occupancy rate in this context reflects the addition of operational beds alongside rising patient volumes. The available figures do not indicate a decline in discharges, which continued to grow year on year.

Why did EBITDA and profit grow slower than revenue?

Rainbow’s EBITDA and net profit rose more slowly than revenue because the reported EBITDA margin was lower than the previous year’s level. The Q2 FY27 EBITDA margin of 31% was down 245 basis points year on year, although it improved sequentially according to the disclosed quarterly data.

On a sequential basis, EBITDA increased 26.2% and net profit rose 34.1%. Revenue also increased 17% quarter on quarter, based on the figures disclosed alongside the quarterly results. These movements show an improvement from the preceding quarter, while the year-on-year margin comparison remained affected by the lower reported margin.

For investors, the result separates two developments: continued revenue and volume growth, and a moderation in the rate of profit growth. The company’s ability to raise utilisation at recently added facilities will remain relevant because its operating bed base expanded faster than inpatient discharges in Q2 FY27.

How was the Q2 FY27 earnings discussion made available?

Rainbow held its Q2 and H1 FY27 earnings conference call on November 2, 2026, at 10:00 AM IST, and subsequently made the audio recording available on its investor relations website. The call covered financial and operational performance for the quarter and half year ended September 30, 2026.

The disclosure was filed with the National Stock Exchange of India, where the company trades under the RAINBOW symbol, and with BSE Limited, where its scrip code is 543524. Making the audio available allows shareholders and analysts to review management’s comments on the reported figures and operating developments.

The earnings call was hosted by IIFL Capital. The company’s stated financial highlights on the call included ₹548 crore of operating revenue, ₹170 crore of EBITDA and a 31% quarterly EBITDA margin. The results for the quarter and half year were described as unaudited.

What do the results mean for investors and hospital operations?

Rainbow’s Q2 FY27 figures show that patient activity rose across its key services while its hospital network continued to expand. Revenue growth of 23.2% was supported by increases in outpatient consultations, inpatient discharges and deliveries, all of which are central operating measures for a paediatric and maternity-focused hospital operator.

The data also show that additional capacity has not yet translated into a higher occupancy rate. With operational beds up 18% and inpatient discharges up 15%, occupancy declined to 49.2%. This makes bed utilisation an important operating measure alongside revenue, margin and profit in assessing the impact of the new Nellore and Guntur facilities.

For the broader hospital sector, Rainbow’s reported performance illustrates how network expansion can increase revenue opportunities while also changing near-term utilisation and margin comparisons. The company did not provide a forward financial target in the supplied earnings-call material, so the reported data do not establish a forecast for subsequent quarters.

Conclusion

Rainbow delivered Q2 FY27 revenue growth of 23.2% to ₹548 crore, with higher inpatient, outpatient and delivery volumes supporting the result. EBITDA of ₹170 crore and net profit of ₹83.9 crore also increased year on year, but EBITDA margin was lower than the comparable quarter despite sequential improvement.

The next disclosures to watch are subsequent quarterly updates on occupancy, patient volumes and the contribution from the Nellore and Guntur hospitals. These measures will indicate how the expanded 1,910-bed operating network is being utilised after Q2 FY27.